United Therapeutics Aktie
WKN: 923818 / ISIN: US91307C1027
|
29.07.2014 12:10:01
|
United Therapeutics Q2 Profit Rises - Quick Facts
(RTTNews) - United Therapeutics Corp. (UTHR) said that its net income for the second-quarter ended June 30, 2014 rose to $111.9 million or $2.10 per share, from $79.9 million or $1.52 per share for the same quarter in 2013.
Non-GAAP earnings for the quarter were $122.4 million, compared to $125.1 million for the same quarter in 2013. Non-GAAP earnings per share was $2.30 down from $2.38 in the year ago quarter.
Total revenues for the quarter were $322.8 million, up from $280.6 million last year.
Analysts polled by Thomson Reuters expected the company to report earnings of $1.75 per share and revenues of $308.04 million for the quarter. Analysts' estimates typically exclude special items.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu United Therapeutics Corp.mehr Nachrichten
Analysen zu United Therapeutics Corp.mehr Analysen
Aktien in diesem Artikel
| United Therapeutics Corp. | 280,50 | 0,75% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.